When it comes to the quality of care provided to patients, there is wide variation or gaps within the health-care system, according to a study by the National Committee for Quality Assurance.
When it comes to the quality of care provided to patients, there is wide variation or gaps within the health-care system, according to a study by the National Committee for Quality Assurance. These "quality gaps," including at least two in ob/gyn care, led to more than 79,000 avoidable deaths and added an estimated $1.8 million in costs. The quality gap, according to NCQA, is the difference between the national average for a given clinical measure and the performance of the top 10% of health plans, reported Medical Economics (11/19/04).
Looking at specific clinical measures, the study found that the variation in the quality of care for breast cancer screening led to as many as 1,000 avoidable deaths and $48 million in avoidable costs. The differences in prenatal care led to as many as 1,400 avoidable deaths. Likewise, the discrepancy in cervical cancer screening led to as many as 800 avoidable deaths. The avoidable costs of these last two clinical measures were not available.
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More
Hyperoxygenation use not linked to neonatal outcomes
April 23rd 2024Recent research evaluated the impact of maternal hyperoxygenation on neonatal Apgar scores, revealing no significant enhancement in outcomes among women with pathologic fetal heart rate tracing and suggesting limited efficacy of hyperoxygenation therapy in this context.
Read More
Study finds antihypertensive treatment reduces uterine fibroids risk
April 23rd 2024A recent study revealed that patients with untreated or new-onset hypertension face elevated chances of uterine fibroid diagnosis, underscoring the potential of antihypertensive therapy in mitigating this risk among midlife individuals.
Read More